Paris, Friday January 14, 2022 – After a catastrophic 2020, the Biomedicine Agency communicates on a 19.3% increase in transplant activity compared to 2020. Thus, in 2021, there are 5,273 transplants which were made possible thanks to 1,392 deceased donors and 521 living donors.
The fruit of the battle of the Biomedicine Agency
Throughout 2020 and 2021, the Biomedicine Agency has implemented systems aimed at maintaining transplant activity despite the health crisis.
In particular, it issued recommendations in March 2021, encouraging the continuation of transplant activities in the context of an epidemic rebound. From 2020, she led the national committee to monitor the impact of the Covid-19 epidemic on the organ and tissue harvesting and transplant activity at the baptismal font. Made up of representatives of patient associations, transplant professionals, representatives of the Ministry of Health and members of the Biomedicine Agency, it has adapted the pace of its meetings to the fluctuations of the epidemic. ” In 2021, 12 meetings were thus held by videoconference in order to share, in almost real time with all the members of the committee, the information available to the Biomedicine Agency, and to respond, within the limits of the competences of the Agency, to the concerns of stakeholders underlines the Agency.
|Chart. Transplants performed in France since 2017|
2021: a decrease compared to 2017
But, overall, while transplant activity increased between 2020 and 2021, the numbers of transplants are lower than in 2017 for all organs.
Another downside, the agency observes a slight increase in the rate of refusal of levies on deceased persons, which stood at 33.6% in 2021, against 33% in 2020.
Note, however, that this year 2021 will also have been that of the first French transplant of islets of Langerhans carried out at the Lille University Hospital in December.
Doubtful patient associations
But patient associations are still waiting. Thus, in a joint press release, they point to a ” decline of the transplant in France [qui] began long before the health crisis, which further amplified it “, they also denounce”
the inadequacy of public actions aimed at developing » transplant activity. Therefore, they believe that ” the positive tone of the communication from the Biomedicine Agency should not overshadow the implications of these figures for patients on the waiting list, nor their deep distress: immense anxiety, reduced chances of being transplanted, increased duration of waiting, aggravations and deaths. During the year 2020, nearly a thousand of them thus died out, for lack of a transplant. ».